U.S. Water Utilities Stock News

Why Kilroy Realty is on investors’ radar today Kilroy Realty (KRC) has been drawing attention after a period of mixed share performance, with the stock showing a small 1 year total return but weaker moves over the past month and past 3 months. For a real estate investment trust focused on office and life science properties, those return figures invite a closer look at how its current valuation lines up with recent fundamentals, including revenue of about US$1.13b and net income of roughly...

In January 2026, Xerox Holdings and Lexmark, now a combined company, unveiled a unified suite of AI-enabled retail technology solutions at NRF 2026: Retail’s Big Show in New York, highlighting end-to-end offerings spanning IT, production print, digital workflows, signage, and vision AI for store operations. This collaboration underscores how integrating Xerox’s digital workflow and print capabilities with Lexmark’s retail-focused devices and vision AI can create a single platform that...

If you are wondering whether Raymond James Financial is priced attractively right now, it helps to start by looking at how the current share price lines up with different measures of value. The stock last closed at US$170.06, with a 1.3% decline over the past 7 days, a 2.4% return over the last 30 days, a 3.9% return year to date, a 1.1% return over 1 year, a 50.5% return over 3 years, and a 186.9% return over 5 years. Recent news coverage has focused on Raymond James Financial in the...

Hesai Group recently drew attention after analysis highlighted strong short-term earnings and sales momentum, alongside a highly positive technical setup, including a perfect technical rating. A key element was the identification of a ‘Pocket Pivot’ pattern, a technical signal that often attracts institutional traders looking for potential breakouts. Next, we will examine how this combination of earnings momentum and the Pocket Pivot signal shapes Hesai Group’s broader investment...

If you are wondering whether Lumen Technologies at around US$8.39 still offers value or has already run too far, you are not alone. The stock shows returns of 2.2% over 7 days, 8.0% over 30 days, 9.1% year to date, 45.9% over 1 year and 58.3% over 3 years, while the 5 year return sits at a 36.9% decline. Recent attention on Lumen has been shaped by ongoing coverage of its turnaround efforts and balance sheet position, as investors weigh how the company responds to its debt load and industry...

Event context and recent share performance ICON (NasdaqGS:ICLR) has drawn investor attention after a period of mixed share performance, with a small 1 day gain of 4.7% and broadly flat movement over the past week. Over the past month, the stock shows a 3.2% return, while the past 3 months reflect a 2.7% gain. The year to date figure and 1 year total return are both negative. See our latest analysis for ICON. With the share price at $184.87, ICON’s recent 4.7% 1 day share price return...

Investors may be wondering if Crinetics Pharmaceuticals at around US$55.41 per share is still offering fair value, or if the recent excitement has already been priced in. The stock shows a flat 7 day return, while the 30 day return is 12.5%, year to date is 18.6%, and the 1 year return is 43.4%, with a very large 5 year gain of 282.9%. This performance may have changed how the market views its risk and potential. Recent coverage has focused on Crinetics Pharmaceuticals as a growth oriented...

If you are wondering whether NetApp at around US$97 per share still offers value, you are not alone. This article walks through what the current price might mean for long term investors. The stock has seen a 9.8% decline over the last 7 days and a 12.5% decline over the last 30 days, on top of an 8.8% decline year to date and a 21.4% decline over the last year, even though the 3 year and 5 year returns sit at 56.1% and 58.6% respectively. These moves have come alongside ongoing interest in...

Institutional buying puts American Axle & Manufacturing Holdings (AXL) in focus SAMSON ROCK CAPITAL LLP has disclosed the purchase of more than 1 million American Axle & Manufacturing Holdings (AXL) shares, a move that brings fresh attention to the stock and its recent performance. See our latest analysis for American Axle & Manufacturing Holdings. The SAMSON ROCK CAPITAL LLP purchase comes as momentum in American Axle & Manufacturing Holdings has been picking up, with a 30 day share price...

Terex Corporation (NYSE:TEX) has appointed Namita Jindal as Senior Vice President and Chief AI and Data Officer. Jindal will lead the company’s AI, data and broader digital transformation efforts. The new leadership role signals a company wide push to use data and automation across operations. Terex, a global manufacturer of lifting and material handling equipment, is increasing its focus on how software, data and connected machines fit alongside its core hardware business. Across...

WD-40 Company recently reported first-quarter 2026 results, with sales of US$154.42 million edging above the prior year while net income and earnings per share were slightly lower, and the company also completed a share repurchase of 124,000 shares for US$28.19 million under its existing program. At the same time, management reaffirmed its fiscal 2026 guidance for higher full-year net sales, operating income, and diluted earnings per share compared with 2025 pro forma results, underscoring...

CoastalSouth Bancshares (COSO) has wrapped up FY 2025 with fourth quarter revenue of US$21.0 million and basic EPS of US$0.60, while trailing twelve month revenue and EPS came in at US$78.8 million and US$2.24 respectively. Over recent quarters the company has seen revenue move from US$18.0 million in Q1 2025 to US$21.0 million in Q4 2025, with quarterly EPS ranging between US$0.49 and US$0.60 over the same period. This gives investors a clearer view of the earnings base behind the latest...

Earlier in January 2026, Ascendis Pharma A/S reported positive Week 52 topline Phase 2 COACH trial results for its once-weekly TransCon CNP and TransCon hGH combination in children with achondroplasia, alongside amending its Articles of Association to allow for new warrant grants. The COACH data highlighted durable growth, improved body proportionality, and a safety profile consistent with monotherapies, reinforcing TransCon CNP’s potential backbone role in treating achondroplasia as...

Earlier in January, JPMorgan analyst Richard Shane downgraded OneMain Holdings, citing mounting pressure on its borrowers from high prices and muted wage growth, while Bloomberg reported that TPG agreed to buy about US$2.40 billion of OneMain’s loans through June 2028 under an expanded forward-flow deal. This combination highlights a tension between rising credit risk concerns and OneMain’s use of loan sales to TPG to recycle capital for further lending. We’ll now examine how the analyst...

Ally Financial FY 2025 Results Snapshot Ally Financial (ALLY) has wrapped up FY 2025 with Q4 revenue of US$1,892 million and basic EPS of US$0.97, rounding out a trailing twelve month EPS of US$2.41 and net income of US$742 million. The company has seen revenue move from US$6,751 million to US$7,374 million on a trailing basis, while quarterly EPS has ranged from a loss of US$0.82 in Q1 2025 to US$1.20 in Q3 2025. This provides investors with a fuller view of how profitability has evolved...

For investors wondering whether Wells Fargo is still a solid value play at today’s price or if the easy money has already been made, this article walks through what the current numbers suggest. The stock last closed at US$86.12, with a 3.5% decline over 7 days and an 8.7% decline over 30 days, while still showing a 13.5% gain over 1 year, 105.4% over 3 years and 220.3% over 5 years. Recent headlines have focused on Wells Fargo’s ongoing efforts to simplify its business model and address past...

If you are wondering whether Carlyle Group’s current share price lines up with its underlying worth, you are not alone. This article is built to help you weigh what you are really paying for. The stock most recently closed at US$62.42, with returns of 13.2% over the past year and a very large gain over the last 5 years, while the past week saw a 4.8% decline that tempers the shorter term picture. Recent headlines around Carlyle Group have focused on its position in the global alternative...

If you are looking at Teladoc Health and wondering whether the current share price reflects its true value, you are not alone. The stock last closed at US$6.16, with returns of a 6.8% decline over 7 days, 15.2% decline over 30 days, 12.6% decline year to date, 37.7% decline over 1 year, 77.2% decline over 3 years and 97.8% decline over 5 years. Recent coverage around Teladoc has focused on its role as a major telehealth provider, with attention on how virtual care fits into broader...

What the latest earnings shock means for Liberty Broadband Liberty Broadband (LBRD.K) is back in focus after its recent Q3 2025 earnings beat on EPS but missed revenue expectations, a mix that has added to selling pressure and investor uncertainty. See our latest analysis for Liberty Broadband. At around $43.72, Liberty Broadband’s recent share price slide, including a 22.18% 90 day share price return and a 39.61% 1 year total shareholder return, points to fading momentum as investors react...

Box, Inc. recently announced the general availability of Box Extract, an AI-powered tool that uses models from Google, Anthropic, and OpenAI to convert unstructured enterprise content into structured metadata within Box. This launch matters because it pushes Box further into AI-enabled content management, letting customers build custom “Extract Agents” that automate complex, document-heavy workflows across sectors like finance, government, media, insurance, and legal. We’ll now examine how...

Snap-on (NYSE:SNA) shares have come under pressure recently, sparking fresh debate over the company’s fundamentals and long term prospects. Investors are weighing the recent share price slip against views of solid operations in tools, diagnostics, and shop solutions. The discussion centers on whether current levels reflect an attractive entry point or ongoing concerns over valuation and earnings growth. Snap-on sits at the intersection of professional tools, diagnostics, and shop equipment,...

Metropolitan Bank Holding (MCB) just closed out FY 2025 with Q4 revenue of US$85.6 million and basic EPS of US$2.83, supported by net income of US$28.9 million. Over the past year, revenue has ranged from US$56.0 million to US$85.6 million per quarter while quarterly EPS moved between US$0.68 and US$2.83. This gives you a clear view of how the top line and EPS have tracked together through FY 2025. With a trailing net interest margin at 3.88% and a net profit margin of 25.6% for the last...

Recent screening work around growth investing criteria has pushed Nutex Health (NUTX) into focus, after it met strict tests tied to earnings revisions, earnings surprises, sales growth, and operating margin trends. See our latest analysis for Nutex Health. The recent growth screen interest comes after a period of sharp volatility, with a 1 day share price return of a 4.42% decline and a 7 day return of an 11.41% decline, alongside a 90 day share price return of 25.29% and a very large 1 year...

Why First Bancorp’s Latest Earnings Matter for Shareholders First Bancorp (FBNC) released fourth quarter and full year 2025 results, with higher net interest income and net income than a year earlier, putting the stock in sharper focus for investors. See our latest analysis for First Bancorp. The earnings release has come alongside a sharp move in the stock, with a 1-day share price return of 4.76% and a 30-day share price return of 14.52%. The 1-year total shareholder return of 40.54%...